Literature DB >> 19870912

A FURTHER CONTRIBUTION TO VITAMIN C THERAPY IN EXPERIMENTAL POLIOMYELITIS.

C W Jungeblut1.   

Abstract

1. Multiple paralytic doses of poliomyelitis virus (RMV strain), when brought together with small amounts of synthetic ascorbic acid in vitro, are rendered non-infectious as determined by intracerebral injection of such mixtures into rhesus monkeys. 2. Vitamin C administration to monkeys infected intranasally with the RMV strain produces results which differ in accordance with the technique employed for nasal instillation. With an infection of maximum severity, induced by flooding the nasal portal of entry with large amounts of virus, vitamin C administration fails to exert any demonstrable influence on the course of the disease. With a less forceful method of droplet instillation, the picture of the disease in control animals becomes so variable that the results cannot be easily interpreted; but the available data suggest that vitamin C treatment may be a factor in converting abortive attacks into an altogether non-paralytic infection. 3. The administration of synthetic vitamin C to monkeys infected intracerebrally with small doses of the RMV strain gives results comparable to those previously obtained with this substance in monkeys infected intracerebrally with the Aycock strain of poliomyelitis virus. 4. The implications of the findings are discussed.

Entities:  

Year:  1939        PMID: 19870912      PMCID: PMC2133810          DOI: 10.1084/jem.70.3.315

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  6 in total

1.  POLIOMYELITIS: VITAMIN B DEFICIENCY A POSSIBLE FACTOR IN SUSCEPTIBILITY.

Authors:  W J McCormick
Journal:  Can Med Assoc J       Date:  1938-03       Impact factor: 8.262

2.  VITAMIN C IN RELATION TO EXPERIMENTAL POLIOMYELITIS : WITH INCIDENTAL OBSERVATIONS ON CERTAIN MANIFESTATIONS IN MACACUS RHESUS MONKEYS ON A SCORBUTIC DIET.

Authors:  A B Sabin
Journal:  J Exp Med       Date:  1939-03-31       Impact factor: 14.307

3.  INACTIVATION OF POLIOMYELITIS VIRUS IN VITRO BY CRYSTALLINE VITAMIN C (ASCORBIC ACID).

Authors:  C W Jungeblut
Journal:  J Exp Med       Date:  1935-09-30       Impact factor: 14.307

4.  VITAMIN C CONTENT OF MONKEY TISSUES IN EXPERIMENTAL POLIOMYELITIS.

Authors:  C W Jungeblut; R R Feiner
Journal:  J Exp Med       Date:  1937-09-30       Impact factor: 14.307

5.  FURTHER OBSERVATIONS ON VITAMIN C THERAPY IN EXPERIMENTAL POLIOMYELITIS.

Authors:  C W Jungeblut
Journal:  J Exp Med       Date:  1937-09-30       Impact factor: 14.307

6.  VITAMIN C THERAPY AND PROPHYLAXIS IN EXPERIMENTAL POLIOMYELITIS.

Authors:  C W Jungeblut
Journal:  J Exp Med       Date:  1937-01-01       Impact factor: 14.307

  6 in total
  4 in total

Review 1.  Can natural products modulate cytokine storm in SARS-CoV2 patients?

Authors:  Doha H Abou Baker
Journal:  Biotechnol Rep (Amst)       Date:  2022-06-09

2.  Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects.

Authors:  Sebastian J Padayatty; Andrew Y Sun; Qi Chen; Michael Graham Espey; Jeanne Drisko; Mark Levine
Journal:  PLoS One       Date:  2010-07-07       Impact factor: 3.240

Review 3.  Sanitizing agents for virus inactivation and disinfection.

Authors:  Qianyu Lin; Jason Y C Lim; Kun Xue; Pek Yin Michelle Yew; Cally Owh; Pei Lin Chee; Xian Jun Loh
Journal:  View (Beijing)       Date:  2020-05-24

Review 4.  Intravenous vitamin C for reduction of cytokines storm in acute respiratory distress syndrome.

Authors:  Alberto Boretti; Bimal Krishna Banik
Journal:  PharmaNutrition       Date:  2020-04-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.